IGC Pharma Announces Collaboration to Integrate AI into Clinical TrialsPosted by On

POTOMAC, Md.–(BUSINESS WIRE)– #AD–IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced an Artificial Intelligence (AI) collaboration with Los Andes University’s Center for Research and Training in Artificial Intelligence (“CINFONIA”). The partnership aims to leverage Generative AI (AI) to analyze variations in disease signatures among patients, enabling IGC Pharma to identify individuals more likely to respond to treatment and subsequently accelerate the delivery of treat

Source link


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.